ACTIVE

BIOMDRIN

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
2,8 k €
-80.7% YoY
Gross margin
4,1 k €
-79.1% YoY
Equity
22,3 k €
+14.3% YoY

What does BIOMDRIN do?

BIOMDRIN is a Private limited company incorporated in 2024. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Schilde.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 1004.523.585
Incorporation
10/01/2024
Legal form
Private limited company
Registered office
Den Aard 18 box A
2970 Schilde · FlandreSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations72109Research and experimental development on natural sciences and engineering72190Other research and experimental development on natural sciences and engineering
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20252024
Income statement
Gross margin4,1 k €19,7 k €
EBITDA3,6 k €19,3 k €
Operating result3,6 k €18,1 k €
Net result2,8 k €14,5 k €
Balance sheet
Equity22,3 k €19,5 k €
Total assets38,3 k €29,5 k €
Cash11,7 k €1,1 k €
Debts15,9 k €10,0 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active

Active mandates

Anthony Van Campen

Director · since 10 janvier 2024

Active
Josue Jimenez Vazquez

Director · since 10 janvier 2024

Active
Patrick van der Linden

Director · since 10 janvier 2024

Active
At this address

Other companies at this address

CompanyCBE no.
Dandelion● Active
1013.436.105
DW Max● Active
1017.456.358
Annual accounts

Full financial information

20252024
Type of accountMicro modelMicro model
Start of the financial year01/01/202509/01/2024
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months12 months
Filing date27/07/202618/07/2025
General meeting29/06/202630/06/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202529/06/202627/07/2026DutchPDF
Micro model31/12/202430/06/202518/07/2025DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active

Active mandates

Anthony Van Campen

Director · since 10 janvier 2024

Active
Josue Jimenez Vazquez

Director · since 10 janvier 2024

Active
Patrick van der Linden

Director · since 10 janvier 2024

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other12/01/2024
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20252,8 k €↓
  2. 2024
    Annual accounts 202414,5 k €
  3. 10/01/2024
    IncorporationPrivate limited company